Zinc in PDB 2lv9: Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A
Enzymatic activity of Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A
All present enzymatic activity of Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A:
2.1.1.43;
Zinc Binding Sites:
The binding sites of Zinc atom in the Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A
(pdb code 2lv9). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the
Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A, PDB code: 2lv9:
Jump to Zinc binding site number:
1;
2;
Zinc binding site 1 out
of 2 in 2lv9
Go back to
Zinc Binding Sites List in 2lv9
Zinc binding site 1 out
of 2 in the Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn201
b:0.0
occ:1.00
|
ND1
|
A:HIS143
|
2.1
|
0.0
|
1.0
|
SG
|
A:CYS121
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS146
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS123
|
2.3
|
0.0
|
1.0
|
HG3
|
A:GLN177
|
2.5
|
0.0
|
1.0
|
HB2
|
A:HIS143
|
2.8
|
0.0
|
1.0
|
CE1
|
A:HIS143
|
3.1
|
0.0
|
1.0
|
CG
|
A:HIS143
|
3.1
|
0.0
|
1.0
|
H
|
A:HIS143
|
3.2
|
0.0
|
1.0
|
HE1
|
A:HIS143
|
3.3
|
0.0
|
1.0
|
HB3
|
A:CYS121
|
3.3
|
0.0
|
1.0
|
HB3
|
A:CYS123
|
3.3
|
0.0
|
1.0
|
CB
|
A:HIS143
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS121
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS123
|
3.5
|
0.0
|
1.0
|
CG
|
A:GLN177
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS146
|
3.5
|
0.0
|
1.0
|
HB2
|
A:CYS146
|
3.6
|
0.0
|
1.0
|
H
|
A:CYS123
|
3.6
|
0.0
|
1.0
|
HB3
|
A:CYS146
|
3.7
|
0.0
|
1.0
|
CD
|
A:GLN177
|
3.9
|
0.0
|
1.0
|
HB2
|
A:CYS121
|
4.0
|
0.0
|
1.0
|
HD11
|
A:ILE122
|
4.0
|
0.0
|
1.0
|
N
|
A:HIS143
|
4.0
|
0.0
|
1.0
|
HG2
|
A:GLN177
|
4.1
|
0.0
|
1.0
|
O
|
A:PHE125
|
4.2
|
0.0
|
1.0
|
NE2
|
A:HIS143
|
4.2
|
0.0
|
1.0
|
HB2
|
A:CYS123
|
4.2
|
0.0
|
1.0
|
CD2
|
A:HIS143
|
4.2
|
0.0
|
1.0
|
OE1
|
A:GLN177
|
4.3
|
0.0
|
1.0
|
HB3
|
A:HIS143
|
4.3
|
0.0
|
1.0
|
HB3
|
A:PHE125
|
4.3
|
0.0
|
1.0
|
CA
|
A:HIS143
|
4.4
|
0.0
|
1.0
|
NE2
|
A:GLN177
|
4.4
|
0.0
|
1.0
|
N
|
A:CYS123
|
4.4
|
0.0
|
1.0
|
HB2
|
A:GLN177
|
4.4
|
0.0
|
1.0
|
CB
|
A:GLN177
|
4.5
|
0.0
|
1.0
|
HE21
|
A:GLN177
|
4.5
|
0.0
|
1.0
|
HB3
|
A:GLN177
|
4.5
|
0.0
|
1.0
|
CA
|
A:CYS123
|
4.6
|
0.0
|
1.0
|
HA
|
A:GLN142
|
4.6
|
0.0
|
1.0
|
H
|
A:PHE125
|
4.6
|
0.0
|
1.0
|
CA
|
A:CYS121
|
4.7
|
0.0
|
1.0
|
HD13
|
A:ILE122
|
4.8
|
0.0
|
1.0
|
HB3
|
A:GLN142
|
4.8
|
0.0
|
1.0
|
HB3
|
A:ALA173
|
4.8
|
0.0
|
1.0
|
CD1
|
A:ILE122
|
4.9
|
0.0
|
1.0
|
HD2
|
A:PHE125
|
4.9
|
0.0
|
1.0
|
CA
|
A:CYS146
|
4.9
|
0.0
|
1.0
|
H
|
A:ILE122
|
4.9
|
0.0
|
1.0
|
HE22
|
A:GLN177
|
5.0
|
0.0
|
1.0
|
C
|
A:CYS121
|
5.0
|
0.0
|
1.0
|
|
Zinc binding site 2 out
of 2 in 2lv9
Go back to
Zinc Binding Sites List in 2lv9
Zinc binding site 2 out
of 2 in the Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Solution uc(Nmr) Structure of the Phd Domain of Human MLL5, Northeast Structural Genomics Consortium Target HR6512A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn202
b:0.0
occ:1.00
|
SG
|
A:CYS135
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS138
|
2.3
|
0.0
|
1.0
|
SG
|
A:CYS163
|
2.4
|
0.0
|
1.0
|
SG
|
A:CYS160
|
2.4
|
0.0
|
1.0
|
H
|
A:CYS160
|
2.8
|
0.0
|
1.0
|
HG21
|
A:VAL140
|
3.2
|
0.0
|
1.0
|
H
|
A:CYS138
|
3.2
|
0.0
|
1.0
|
HB2
|
A:CYS163
|
3.4
|
0.0
|
1.0
|
HB3
|
A:CYS138
|
3.5
|
0.0
|
1.0
|
HB3
|
A:CYS135
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS135
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS163
|
3.5
|
0.0
|
1.0
|
CB
|
A:CYS138
|
3.6
|
0.0
|
1.0
|
CB
|
A:CYS160
|
3.6
|
0.0
|
1.0
|
HB3
|
A:CYS160
|
3.6
|
0.0
|
1.0
|
N
|
A:CYS160
|
3.7
|
0.0
|
1.0
|
HB3
|
A:LYS137
|
3.7
|
0.0
|
1.0
|
HB2
|
A:CYS135
|
3.8
|
0.0
|
1.0
|
HG22
|
A:VAL140
|
4.0
|
0.0
|
1.0
|
H
|
A:CYS163
|
4.0
|
0.0
|
1.0
|
CG2
|
A:VAL140
|
4.0
|
0.0
|
1.0
|
N
|
A:CYS138
|
4.0
|
0.0
|
1.0
|
HA
|
A:LEU159
|
4.1
|
0.0
|
1.0
|
CA
|
A:CYS160
|
4.2
|
0.0
|
1.0
|
HB3
|
A:CYS163
|
4.2
|
0.0
|
1.0
|
CA
|
A:CYS138
|
4.4
|
0.0
|
1.0
|
HG23
|
A:VAL140
|
4.4
|
0.0
|
1.0
|
HB2
|
A:CYS138
|
4.4
|
0.0
|
1.0
|
N
|
A:CYS163
|
4.4
|
0.0
|
1.0
|
H
|
A:VAL140
|
4.5
|
0.0
|
1.0
|
HB2
|
A:CYS160
|
4.5
|
0.0
|
1.0
|
CA
|
A:CYS163
|
4.6
|
0.0
|
1.0
|
HB2
|
A:ARG162
|
4.6
|
0.0
|
1.0
|
O
|
A:CYS160
|
4.7
|
0.0
|
1.0
|
C
|
A:CYS160
|
4.8
|
0.0
|
1.0
|
HD2
|
A:LYS137
|
4.8
|
0.0
|
1.0
|
C
|
A:LEU159
|
4.8
|
0.0
|
1.0
|
CB
|
A:LYS137
|
4.8
|
0.0
|
1.0
|
HD22
|
A:LEU159
|
4.9
|
0.0
|
1.0
|
CA
|
A:CYS135
|
4.9
|
0.0
|
1.0
|
H
|
A:LYS137
|
4.9
|
0.0
|
1.0
|
CA
|
A:LEU159
|
4.9
|
0.0
|
1.0
|
HD21
|
A:LEU159
|
4.9
|
0.0
|
1.0
|
HG11
|
A:VAL140
|
5.0
|
0.0
|
1.0
|
C
|
A:CYS138
|
5.0
|
0.0
|
1.0
|
HA
|
A:CYS163
|
5.0
|
0.0
|
1.0
|
|
Reference:
A.Lemak,
A.Yee,
S.Houliston,
M.Garcia,
H.Wu,
J.Min,
G.T.Montelione,
C.Arrowsmith.
uc(Nmr) Solution Structure of the Human MLL5 Phd Domain (Casp Target) To Be Published.
Page generated: Thu Oct 17 01:55:48 2024
|